Thanks ... the debt did catch my eye, but again, comparatively speaking, it's not particularly onerous. Still, you might be right ... it's the only negative I can see.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025